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Abstract
Mesangial cells are glomerular cells of stromal origin. During immune complex mediated crescentic glomerulonephritis
(Crgn), infiltrating and proliferating pro-inflammatory macrophages lead to crescent formation. Here we have hypothesised
that mesangial cells, given their mesenchymal stromal origin, show similar immunomodulatory properties as mesenchymal
stem cells (MSCs), by regulating macrophage function associated with glomerular crescent formation. We show that rat
mesangial cells suppress conA-stimulated splenocyte proliferation in vitro, as previously shown for MSCs. We then
investigated mesangial cell-macrophage interaction by using mesangial cells isolated from nephrotoxic nephritis (NTN)-
susceptible Wistar Kyoto (WKY) and NTN-resistant Lewis (LEW) rats. We first determined the mesangial cell transcriptome in
WKY and LEW rats and showed that this is under marked genetic control. Supernatant transfer results show that WKY
mesangial cells shift bone marrow derived macrophage (BMDM) phenotype to M1 or M2 according to the genetic
background (WKY or LEW) of the BMDMs. Interestingly, these effects were different when compared to those of MSCs
suggesting that mesangial cells can have unique immunomodulatory effects in the kidney. These results demonstrate the
importance of the genetic background in the immunosuppressive effects of cells of stromal origin and specifically of
mesangial cell-macrophage interactions in the pathophysiology of crescentic glomerulonephritis.
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Introduction
Macrophage infiltration plays a crucial role in the development
of crescentic glomerulonephritis [1–3]. Under pathologic condi-
tions, activated macrophages secrete a variety of inflammatory
mediators and stimulate resident cells such as mesangial cells
(MCs) toward activation and survival [4,5]. Once activated, MCs
express chemokines (i.e monocyte chemoattractant protein 1;
MCP-1) and accelerate accumulation of macrophages, leading to
progression of glomerular injury [6,7].
Depletion of macrophages [8] or inhibition of mesangial cell
proliferation and activation [9,10] attenuates glomerular injury in
rodent models of glomerulonephritis, suggesting that both
macrophage and mesangial cell function contribute to the
progression of renal injury in glomerulonephritis. We have been
investigating the relative role of MCs and macrophages in the
nephrotoxic nephritis (NTN) model of crescentic glomerulone-
phritis (Crgn) in the Wistar Kyoto (WKY) rat. This inbred rat
strain is uniquely susceptible to macrophage-dependant NTN
[11]. Bone marrow transplantation studies between the NTN-
susceptible WKY and NTN-resistant LEW rats together with
mesangial cell activation assays show that resident renal cells
account for about 10% of glomerular crescent formation (90% of
the Crgn susceptibility is caused by circulating cells). The intrinsic
renal contribution may be, in part, due to mesangial cell secretion
of MCP-1 upon stimulation with TNF-a [4,7] since WKY cells
secrete increased levels of MCP-1 when compared with LEW
mesangial cells indicating that there is a genetic predisposition for
mesangial cell activation [7].
MCs are modified smooth muscle cells that provide structural
support for glomerular capillary loops [12]. They are stromal
cells of mesenchymal origin and may therefore have properties
in common with bone marrow derived mesenchymal stem cells
(MSCs). These latter have been used in cell transfer studies to
modify experimental glomerulonephritis in the rat. Elegant
studies by Kunter et al. showed that MSC injection resulted in
rapid recovery from mesangiolysis in rat mesangioproliferative
anti-Thy1.1 glomerulonephritis [13]. The same group used a
similar approach in a more progressive model of glomerulone-
phritis where the Thy1.1 model was aggravated with previous
uninephrectomy of the rats [14]. In this model, MSCs
prevented progressive renal failure but resulted in the formation
of adipose tissue within the glomeruli of the injected rats.
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Another study showed that human MSCs home to and promote
repair of pancreatic islets and renal glomeruli in diabetic NOD/
scid mice [15]. Although these studies showed beneficial effect
of MSC injection on the pathophysiology of experimental
glomerulonephritis, the mechanisms by which MSCs exert their
modulatory function are still under investigation and recent
reports underlie the importance of cell-to-cell communication
through the release of soluble factors by these cells [16].
The secretion of soluble factors together with the inflammatory
profile to which MSCs are exposed constitute key aspects of their
immunomodulatory activity [17] which could also contribute to
renal repair [18]. Notably, monocyte/macrophages have been
shown to play an important regulatory role in enabling MSCs to
acquire their immunosuppressive activity [19,20].
Here we have hypothesised that MCs, given their mesenchy-
mal stromal origin, will acquire regulatory properties in the
inflammatory milieu generated by infiltaring macrophages at an
early stage of Crgn in the WKY NTN. We have also explored
the genetic determinants of this mesangial cell regulation by
using MCs from NTN-susceptible and NTN-resistant rats. We
show the immunosuppressive capacity of rat MCs on splenocyte
proliferation. We also demonstrate that the transcriptome of
mesangial cells from WKY and NTN-resistant Lewis rat is
distinct and this translates into different regulatory effects on
macrophages from the same strains; skewing them towards M1
or M2 activation according to their genetic background. We also
show that MCs and MSCs differ in their macrophage regulatory
properties. We therefore propose that kidney mesangial cells
could have unique immunomodulatory effects in ‘‘fine tuning’’
macrophage activation.
Results
Rat mesangial cells suppress splenocyte proliferation
Since the ability of MSCs to suppress splenocyte proliferation
was previously described [21], we tested whether mesangial cells
can suppress splenocyte proliferation with 3H thymidine immu-
nosuppressive assay. We have assessed WKY splenocyte prolifer-
ation in presence of WKY mesangial cells and similarly LEW
splenocyte proliferation in presence of LEW mesangial cells
(Figure 1A and B). Both strains’ mesangial cells suppressed
significantly their respective splenocyte proliferation showing that
mesangial cells suppress splenocyte proliferation in vitro (Fig-
ure 1A and B).
Rat mesangial cell transcriptome is genetically
determined
We have previously shown that NTN-susceptible WKY MCs
secrete relatively higher levels of MCP-1 when compared with
LEW in both basal and TNFa stimulated MCs, suggesting that
there is a genetically determined mesangial cell activation [4,7].
To study this further, we have performed genome-wide
expression analysis by microarrays in control (basal) and
TNFa-stimulated mesangial cells derived from WKY and
LEW rats. WKY and LEW MC transcriptomes in basal and
activated states formed four distinct clusters in the hierarchical
clustering analysis (Figure 2A). Although the treatment effect
(TNFa) clustered differently from control (basal) samples, the
biggest clustering (height of the dendogram) was obtained
between the inbred rat strains (Figure 2A). Indeed, there were
nearly 4000 differentially expressed genes between WKY and
LEW MCs in the basal state (FDR ,0.05). The top
differentially expressed transcripts (Fc .10; FDR ,0.01) were
validated by qRT-PCR analysis (Figure 2B). When WKY and
LEW mesangial cells’ transcriptomes were compared for
differential expression, KEGG analysis showed the most
significant enrichment for DNA replication (P=2.4161026).
This suggests that genetic determinants of the MC transcrip-
tome reflect a difference in the proliferative status of WKY and
LEW MCs (Figure 2C). Notably, TNFa treatment resulted in a
significant differential expression in 1524 genes in WKY MCs
but only 804 in LEW MCs, indicating also a genetic difference
in response to TNFa stimulation. When LEW and WKY MCs
are stimulated with TNFa, there are specific strain-specific
KEGG pathways showing significant enrichment in microarray
datasets (Figure 2D).
Mesangial cells shift macrophages to either M1 or M2
activation state depending on the genetic background of
the cells
In order to determine whether mesangial cells secrete soluble
factors that shift macrophage expression towards M1/M2
polarisation, we have performed supernatant transfer experi-
ments from rat mesangial cells onto WKY bone marrow derived
macrophages (BMDMs). BMDM expression of M1 and M2
markers were assessed by qRT-PCR following transfer of
supernatants from mesangial cells. To determine whether the
genetic background of macrophages and mesangial cells
influence the potential immunosuppressive properties of mesan-
gial cells, these experiments were performed by using WKY and
LEW BMDMs incubated with either WKY or LEW MC
supernatant (SN). Interestingly, when MC SN from NTN-
susceptible WKY rats were transferred onto WKY BMDMs,
this has led to a significant increase in the expression of Nos2,
Il1b, Tnfa, Il12b (Figure 3A). MC SN from NTN-resistant
LEW rats did not result in a significant increase in expression of
Il1b, Tnfa and Il12b (Figure 3A). When LEW BMDMs were
stimulated with MC supernatants, this has not resulted in a
significant increase in the expression of all M1 markers
(Figure 3A). We next assessed the expression of M2 macrophage
markers such as Mrc1 and Il10 and showed that WKY MC SN
increase LEW BMDM expression of these markers (Figure 3B).
In summary these results suggest that WKY MC SN contain
soluble factors that polarise macrophage expression towards
either M1 or M2 depending of the genetic background of the
macrophages. Similar results were obtained when co-culture
experiments were performed instead of transferring the super-
natant and when supernatant from TNF-a-stimulated cells were
incubated with BMDMs (data not shown).
The effect of bone marrow derived mesenchymal stromal
cells on macrophage gene expression
Because of the previously proven immunomodulatory effects
of MSCs, and their common stromal origin with kidney
mesangial cells, we hypothesised that mesangial cells and MSCs
could have similar effects on macrophage gene expression. To
test this, we cultured bone marrow-derived MSCs and
transferred the supernatants from WKY MSCs to BMDMs to
compare the gene expression in BMDMs following incubation
with MC supernatant (Figure 4). First we show that rat bone-
marrow derived MSC differentiate successfully into adipocytes
and osteogenic cells (Figure 4A and B) assessed by presence of
oil-red-O+ and Alizarin Red S-stained calcium deposits
respectively (Figure 4B). qRT-PCR expression of adiponectin
on MSC-derived adipocytes further confirmed the adipocyte
differentiation (Figure 4B). MC and MSc SN had contrasting
effects on the expression levels of Mmp12, Mrc1 and Il10
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expression (Figure 4C). While MC supernatant from WKY cells
selectively increase LEW BMDM Mrc1 and Il10 expression
(Figure 3B), the same macrophages incubated with WKY MSC
supernatant resulted in a significant decrease in the expression
of these transcripts (Figure 4C). This suggests that MSCs and
MCs have opposite effects on macrophage expression of the
selected M2 markers.
Figure 1. Mesangial cells (MCs) inhibit splenocyte proliferation. Rat MCs were cultured until passage 5 (P5) and incubated with Con-A
stimulated or non-stimulated splenocytes for 72 hours. Cell proliferation was measured by incorporation of tritiated thymidine (3H-TdR). A. Co-culture
of WKY MCs and splenocytes resulted in a significant decrease in ConA-stimulated splenocyte proliferation in both 1:10 and 1:20 ratio of
MC:Splenocyte. **, P,0.001 compared with splenocytes alone. The results are representative of three independent experiments. Cpm, counts per
minute B. Co-culture of LEW MCs and splenocytes resulted in a significant decrease in Con-A-stimulated splenocyte proliferation in both 1:10 and
1:20 ratio of MC:Splenocyte. **, P,0.001 compared to splenocytes alone. The results are representative of three independent experiments. Cpm,
counts per minute.
doi:10.1371/journal.pone.0111452.g001
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Methods
Animals
WKY (WKY/NCrl) and LEW (LEW/Crl) rats were purchased
from Charles River UK. All procedures were performed in
accordance with the United Kingdom Animals (Scientific Proce-
dures) Act, 1986. All the procedures were approved by the Home
Office UK.
Bone marrow-derived macrophage culture
Bone marrow-derived macrophages were obtained and char-
acterised as described previously [4]. Bone marrow-derived cells
were allowed to differentiate in Dulbecco’s Modified Eagle
Medium (DMEM, Gibco) containing 25 mM HEPES buffer
(Sigma), 25% L929-conditioned medium, 25% Fetal Bovine
Serum (Biosera), Penicillin (100 U/ml; Gibco) and Streptomycin
(100 mg/ml; Gibco) and cultured for 5 days on petri dishes (Nunc).
Cells were characterised as macrophages by performing immuno-
histochemistry on methanol-aceton fixed cells for rat ED-1
(Serotec, Oxford, UK) followed by an HRP-labelled anti-mouse
polymer development system (Dako Ltd, UK). We found that
.99% of the differentiated cells were ED-1+ macrophages and
all the primary macrophages used in our study were Cd11b+
(Figure S1).
3H thymidine immunosuppressive assay
In order to measure the anti-proliferative ability of rat WKY or
LEW mesangial cells, these cells were plated at 56104 cells/well in
a 96 well flat bottom plate (Costar), and either 56105 Con-A
stimulated or non-stimulated splenocytes were added for 72 hours.
Cell proliferation was measured by incorporation of tritiated
thymidine (3H-TdR). Cell cultures were pulsed with 0.5 mCi/well
of 3H-TdR (Amersham, UK) and incubated for the last 18 hours.
Cells were then harvested onto filters (Wallac Perkin Elmer, USA)
using a 96-well cell harvester. The results of the incorporated
thymidine were expressed in counts per minute (cpm) and were a
mean of triplicate.
Kidney mesangial and bone marrow-derived
mesenchymal stromal cell culture
Glomeruli from WKY and LEW rats were isolated by sieving as
previously described [4]. Purified glomeruli were digested with
collagenase type 1 (Sigma) for 20 min. The partially digested
glomeruli were cultured in 25-cm2 tissue culture flasks in RPMI
1640 medium (Invitrogen) which contained 20% FCS (Biosera),
10% Penicillin/Streptomycin (Invitrogen), L-glutamine (2 nM,
Invitrogen) and insulin-transferrin-selenite (Sigma). The cultures
were maintained in 37uC, 5% CO2 incubators for 6 days. Medium
was changed every 2 to 3 days thereafter. By day 21 to 30, cells
were subcultured when they reached confluence. These cells were
characterized by immunofluorescence staining using cells that
were cultured on coverslips. They were positive for Thy-1.1
antigen, myosin, and desmin and negative for pancytokeratin,
OX-1, ED-1, and OX-23.
For bone marrow-derived mesencymal stromal cell (MSC)
culture, femurs and tibias from WKY and LEW rats were isolated
and flushed with Hank’s balance salt solution (HBSS; Gibco).
206106 bone marrow-derived cells were incubated in one T150
tissue culture flask in MesenCult MSC Basal Medium (Stemcell)
that contained MSC stimulatory supplement and 0.5% Penicillin/
Streptomycin (Invitrogen). The cultures were maintained in 37uC,
5% CO2 incubators their media was changed every 3–6 days.
After P5, cells were incubated in StemPro Adipogenesis Differen-
tiation Kit (Invitrogen) and characterized by Oil Red O and 2%
Alizarin Red S as MSCs by light microscopy. MSCs were further
characterised as Cd11b(2) cells (Figure S1).
Microarray sample preparation and data analysis
Total RNA was extracted from mesangial cells (P4) using the
TRIzol (Invitrogen) method and purified using RNeasy Plus spin
columns (Qiagen). 100 ng of total RNA was amplified, labelled
and hybridised to Rat Gene 1.0 ST arrays (Affymetrix, Santa
Clara, CA, USA) using the Ambion WT Expression Kit (Life
Technologies) as per manufacturer’s instructions. Mesangial cells
from 3 different biological replicates were used for each strain. For
TNFa stimulation, total RNA extracted from mesangial cells
incubated over-night with DMEM media containing only
recombinant rat TNFa (2 ng/ml) were used. CEL intensity files
were produced using GeneChip Operating Software version 1.4
(Affymetrix) and quality tested using the Affymetrix Expression
Console v1.1.2. All 12 files were suitable for further analysis.
Probe-level data was normalised using robust multichip average
(RMA) [22]. A custom definition file was created using up-to-date
probe information [23] and filtered to exclude probes containing
the 2,520,602 single nucleotide polymorphisms present between
the WKY and LEW genomes. The moderated T test with 40,000
permutations implemented in Statistical Analysis of Microarrays
(SAM) version 3.0 was used to identify differentially expressed
genes at an FDR threshold of 5%. KEGG pathway analysis was
carried out using the functional annotation tools within DAVID,
the Database for Annotation, Visualisation and Integrated
Discovery v6.7 [24]. Ward’s linkage algorithm [25] was used for
hierarchical clustering. Dendrograms were calculated with average
linkage hierarchical clustering using Spearman rank correlation
with Ward metric.
Quantitative RT-PCR
All qRT-PCRs were performed with an ViiA 7 Real-Time PCR
System (Life Technologies). A two-step protocol was used as
previously described [26] beginning with cDNA synthesis with
iScript select (Bio-Rad) followed by PCR using The Brilliant II
SYBR Green QPCR master mix (Agilent). A total of 10 ng of
cDNA per sample was used. ViiA 7 software (Life Technologies)
was used to determine the Ct values. Results were analysed using
Figure 2. Genome-wide expression analysis by microarrays identifies two distinct transcriptomes in WKY and LEW MCs. A.
Dendogram representing the hierarchically clustering using all differentially expressed genes between WKY and LEW MCs in basal (unstimulated) and
TNFa-stimulated cells. This shows that the strain (WKY or LEW) and the treatment (basal or TNFa-stimulated) effects cluster in 4 distinct groups. B.
Validation of the markedly differentially expressed transcripts (fold change .10) by qRT-PCR. The upper panel shows the top differentially expressed
candidates identified by microarray analysis with a false discovery rate (FDR) ,0.01. The positive fold change (FC) values designate up-regulation in
WKY MCs and negative FC values designate up-regulation in LEW MCs in basal conditions. The lower panel shows qRT-PCR validation for the
transcripts showing differential expression in the microarray dataset. n = 4 rats, **, P,0.001. C. KEGG pathway analysis applied to differentially
expressed genes between WKY and LEW MCs in basal state (WKY-LEW)basal and (WKY-LEW)TNFa identified the DNA replication and the vasculature
development pathways as the most significant ones respectively. D. KEGG pathway analysis in LEW and WKY MCs treated with TNFa [(LEW)-(LEW) TNFa
and (WKY)-(WKY)TNF] identified strain-specific pathways (shown in blue in the LEW and red in WKY) upon TNFa stimulation. Note that the DNA-
replication pathway is the most significant one in the WKY MCs following TNFa stimulation.
doi:10.1371/journal.pone.0111452.g002
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the comparative Ct method and each sample was normalised to
the reference gene Hprt, to account for any cDNA loading
differences. The primer sequences used for the qRT-PCR
validation of microarray data are available upon request.
Supernatant transfer experiments
46104 WKY and LEW mesangial or mesanchymal stem cells
were plated in 24-well tissue culture plate (Nunc) in their respective
medium and cultures were maintained in 37uC, 5% CO2
incubators for 2 days. Both mesangial cells and mesanchymal
stem cells were made quiescent in serum-free medium for 24 h
and the mesangial cell and mesanchymal stem cell supernatants
were then transferred onto bone marrow derived macrophage
cultures plated in 6-well tissue culture plate (Nunc) at a density of
16106 cells/well. The BMDMs were incubated in 37uC, 5% CO2
for an additional 24 h. Cell layers were collected for qRT-PCR
analysis of M1 and M2 transcripts.
Statistical analysis
Results are expressed as mean 6 SEM. In supernatant transfer
experiments, statistical differences in mean values between the
unstimulated macrophages (basal) and MSC or MC stimulated
Figure 3. Mesangial cells contain soluble factors polarising macrophages depending on their genetic background. Supernatant
transfer from P5 MCs (WKY or LEW) onto WKY or LEW bone marrow-derived macrophages (BMDMs). A. qRT-PCR assessment of M1 macrophage
markers (Nos2, Il1b, Tnfa, Il12b) in WKY (left panel) and LEW (right panel) BMDMs following incubation with MCs supernatants from both strains. Note
the increased expression of all M1 markers in WKY BMDMs following incubation with WKY MC supernatants. B. qRT-PCR assessment of M2
macrophage markers (Mrc1, Il10) in WKY (left panel) and LEW (right panel) BMDMs following incubation with MCs supernatants from both strains.
Note the increased expression of all M2 markers in LEW BMDMs following incubation with WKY MC supernatants. *, P,0.01; **P,0.001; the results
are representative of two experiments, n = 4 rats/strain used per experiment.
doi:10.1371/journal.pone.0111452.g003
Figure 4. The effect of mesenchymal stem cells on macrophage gene expression. A. To characterise rat MSCs, these cells were
differentiated into adipocytes and osteogenic cells. The undifferentiated MSCs are shown in light microscopy. Scale bars: 50 mM. B. Oil-red-0 and
alizarin Red S staining of WKY MSC-derived adipocytes and osteogenic cells (left panel). Adiponectin expression assessed by qRT-PCR (right panel).
**P,0.001. Scale bars: 50 mM. C. qRT-PCR measurement of M1 (Mmp12, Ccl2) and M2 markers (Mrc1 and Il10) in LEW BMDMs incubated with either
WKY MC or MSC supernatant. Note the opposite effect of MC and MSC supernatants on Mmp12, Mrc1 and Il10 expression in LEW BMDMs. **P,0.001,
the results are representative of two independent experiments, n = 4 rats/strain used per experiment.
doi:10.1371/journal.pone.0111452.g004
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cells were compared using a one-way ANOVA with Newman-
Keuls Comparison test.
Discussion
The immunosuppressive properties of MSCs have been widely
studied both in vitro and in animal models of immune-mediated
disorders and clinical trials are currently underway that employ
MSCs to treat human immunological diseases [27]. The various
molecular mechanisms mediating the immunomodulatory effect of
MSCs on different immune cells are still unclear and there are
now several reports aiming to elucidate the MSC-macrophage
interaction in pathology. ‘MSC-educated’ macrophage activation
has been proposed by several groups [28–30], and recently,
transplantation of mesenchymal stem cells promoted an alterna-
tive pathway of macrophage activation and functional recovery
after spinal cord injury [31]. Although there is a large body of
evidence on the immunomodulatory effects of MSCs, the genetic
determinants of the immunosuppressive effects of these cells is
largely ignored.
In the kidney, mesangial cells are of stromal origin and share a
multitude of phenotypic markers with MSCs such as alpha smooth
muscle actin. To date, the role of mesangial cells in macrophage-
dependent crescentic glomerulonephritis in general was equally
widely studied and there are also reports describing specifically
mesangial cell-macrophage interaction in vitro that occur during
the glomerular inflammation [32,33]. Cytokine secretion by MCs
is thought to play a major role in the pathogenesis of
glomerulonephritis. Our previous work indicated that mesangial
cell activity could be genetically determined as the NTN-
susceptible WKY MCs secrete markedly increase amounts of
MCP-1 when compared with NTN-resistant LEW rats [7]. These
results suggested that mesangial cells could have immunomodu-
latory properties affecting the infiltration and activation of the
macrophages within the inflamed glomerulus. Likewise, we have
shown that macrophage function is genetically determined in
[WKY6LEW] rats and is a determinant of their susceptibility to
macrophage-dependent Crgn [34,35].
In this manuscript, we asked the following question: Do kidney
mesangial cells have similar regulatory effects as mesenchymal
stem cells and if so what is the effect of the genetic background on
macrophage polarisation?
We show that mesangial cells can suppress splenocyte prolifer-
ation as was previously shown for MSCs [36]. We also determined
the transcriptome of WKY and LEW MCs showing marked
differences in gene expression which suggests that it is under
genetic control. Supernatant transfer experiments from mesangial
cells onto macrophages shows that soluble factors present in WKY
MC supernatant could differentiate macrophages into M1 or M2
depending on the genetic background of these cells. Interestingly
the NTN-susceptible WKY BMDMs differentiate into a pro-
inflammatory M1 (increase in Il1b, Nos2, Tnfa, Il12b expression)
phenotype whereas the NTN-resistant LEW BMDMs differentiate
into an anti-inflammatory M2 phenotype (increase in Mrc1 and
Il10) following incubation with WKY MC supernatant. This
suggests that the WKY MC supernatant contain soluble factors
that will polarise macrophage activation according to their genetic
background. In keeping with this, the genetic background of MCs
is important when polarising the macrophages. Indeed, MC
supernatants from different genetic backgrounds differentially
polarise WKY macrophages towards an M1 phenotype. These
results add a novel genetic aspect to the modulatory properties of
stromal cells. Our results also suggested that MSCs and MCs have
distinct effects on macrophage M1 and M2 polarisation underlying
the importance of the possibly unique regulatory effects of MCs in
the kidney. MSCs and MCs polarise macrophages in different
ways regardless of the genetic background suggesting the existence
of epigenetic and/or environmental factors responsible for this
effect.
In summary, these results show the importance of genetic
determinants of mesangial cell activation in glomerular inflam-
mation. This must be taken into consideration in understanding
the unique regulatory effects of these cells on activated macro-
phages in the pathophysiology of crescentic glomerulonephritis.
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Figure S1 Flow cytometry analysis of CD11b surface
expression shows that primary rat macrophages (Mw,
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are Cd11b+ and Cd11b- respectively.
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